Tessera Therapeutics

Tessera Therapeutics is pioneering a new category of genome engineering technology called Gene Writing to cure disease by writing in the code of life. Gene Writing is a versatile technology platform that can permanently make small and large alterations to the human genome. The technology can be used to target single point mutations, insertions and deletions or write entire genes. To apply their technology, Tessera is using tissue-targeting non-viral delivery technology to make genetic alterations where they are needed. With their technology, Tessera is aiming to address major unmet medical needs with potentially curative and accessible therapies.

Jobs: